VOLORIDGE INVESTMENT MANAGEMENT, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$128,000
-82.3%
11,933
-75.6%
0.00%
-83.3%
Q3 2020$723,000
-81.8%
48,814
-71.0%
0.01%
-92.2%
Q4 2019$3,962,000
+759.4%
168,614
+576.3%
0.08%
+862.5%
Q3 2019$461,000
-64.6%
24,931
-64.4%
0.01%
-77.8%
Q2 2019$1,302,000
+57.8%
70,017
+229.8%
0.04%
+63.6%
Q2 2018$825,000
-70.9%
21,227
-79.4%
0.02%
-67.2%
Q1 2018$2,839,000
+121.6%
102,854
+95.9%
0.07%
+11.7%
Q3 2015$1,281,000
-53.9%
52,500
-41.1%
0.06%
-57.4%
Q2 2015$2,778,00089,1580.14%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders